United States · FDA National Drug Code directory
hydroxyprogesterone caproate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 18124-016_4a568c2f-4bef-4528-9b49-d94aa326b9b2
- Product NDC
- 18124-016
- Form
- INJECTION
- Composition / generic term
- hydroxyprogesterone caproate
- Labeler
- Fresenius Kabi Austria GmbH
- Marketing category
- DRUG FOR FURTHER PROCESSING
- Marketing start / end (source format)
- 20110203
- Source listing expiry
- 20261231
Source-listed ingredients
- HYDROXYPROGESTERONE CAPROATE — 250 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE in 1 CARTON (18124-016-01) / 1.1 mL in 1 SYRINGE · 18124-016-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →